Adenoid cystic carcinoma

What changed: Adenoid cystic carcinoma

Cancer page →

Every dated change on the records linked to Adenoid cystic carcinoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Regulatory1Guideline1Milestone5This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordAdenoid cystic carcinoma
Facts on this page last checked
When this page itself was last checked or edited.

2022 · 2

September 2019 · 1

2019-09-17RegulatoryLenvatinib
Lenvatinib: approval (US)
Accelerated approval with pembrolizumab in endometrial cancer (KEYNOTE-146)

2019 · 1

2019MilestoneLenvatinib
Lenvatinib phase 2: median progression-free survival 17.5 months
A milestone in how this cancer is treated.

2013 · 1

2013MilestoneAdenoid cystic carcinoma
Genomic landscape shows NOTCH1 and chromatin-remodelling mutations
A milestone in how this cancer is treated.

2009 · 1

2009MilestoneAdenoid cystic carcinoma
MYB-NFIB fusion identified as the defining genetic event
A milestone in how this cancer is treated.

1859 · 1

1859MilestoneAdenoid cystic carcinoma
Billroth describes the tumour as cylindroma
A milestone in how this cancer is treated.